Kailera Therapeutics Inc
NASDAQ:KLRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kailera Therapeutics Inc
NASDAQ:KLRA
|
US |
|
Oruka Therapeutics Inc
F:HQ1
|
US |
|
N
|
NACCO Industries Inc
XBER:NA6A
|
US |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
XBER:GUV
|
HU |
|
Exchange Income Corp
F:0ON
|
CA |
|
SIMEC Atlantis Energy Ltd
LSE:SAE
|
UK |
|
Charter Hall Social Infrastructure REIT
ASX:CQE
|
AU |
|
C
|
Canon Inc
XMUN:CNN1
|
JP |
|
O
|
OFX Group Ltd
OTC:OZFRY
|
AU |
|
Virgin Money UK PLC
F:42YB
|
UK |
|
B
|
Briscoe Group Ltd
ASX:BGP
|
NZ |
|
Donear Industries Ltd
NSE:DONEAR
|
IN |
|
NACCO Industries Inc
NYSE:NC
|
US |
Shareholder Yield
Current shareholder yield for KLRA is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
KLRA Price
Kailera Therapeutics Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -29% |
| Market Capitalization | 2.7B USD |
| Shares Outstanding | 129 570 000 |
| Percentage of Shares Shorted | 2.07% |
